- Home
- WIT vs GEHC Comparison
WIT vs GEHC Comparison
Compare WIT & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WIT
- GEHC
- Stock Information
- Founded
- WIT 1945
- GEHC 1892
- Country
- WIT India
- GEHC United States
- Employees
- WIT N/A
- GEHC N/A
- Industry
- WIT EDP Services
- GEHC Computer Software: Prepackaged Software
- Sector
- WIT Technology
- GEHC Technology
- Exchange
- WIT Nasdaq
- GEHC Nasdaq
- Market Cap
- WIT 27.8B
- GEHC 33.1B
- IPO Year
- WIT N/A
- GEHC N/A
- Fundamental
- Price
- WIT $2.66
- GEHC $75.14
- Analyst Decision
- WIT Hold
- GEHC Buy
- Analyst Count
- WIT 1
- GEHC 7
- Target Price
- WIT N/A
- GEHC $84.14
- AVG Volume (30 Days)
- WIT 8.8M
- GEHC 3.2M
- Earning Date
- WIT 10-16-2025
- GEHC 10-29-2025
- Dividend Yield
- WIT 4.22%
- GEHC 0.19%
- EPS Growth
- WIT 19.82
- GEHC 41.40
- EPS
- WIT 0.15
- GEHC 4.88
- Revenue
- WIT $10,407,415,639.00
- GEHC $19,967,000,000.00
- Revenue This Year
- WIT $4.71
- GEHC $6.03
- Revenue Next Year
- WIT $5.68
- GEHC $4.61
- P/E Ratio
- WIT $18.35
- GEHC $15.40
- Revenue Growth
- WIT 0.41
- GEHC 2.31
- 52 Week Low
- WIT $2.58
- GEHC $57.65
- 52 Week High
- WIT $3.79
- GEHC $94.80
- Technical
- Relative Strength Index (RSI)
- WIT 39.53
- GEHC 48.23
- Support Level
- WIT $2.58
- GEHC $69.79
- Resistance Level
- WIT $2.67
- GEHC $77.94
- Average True Range (ATR)
- WIT 0.06
- GEHC 1.52
- MACD
- WIT -0.01
- GEHC 0.02
- Stochastic Oscillator
- WIT 20.70
- GEHC 53.74
About WIT Wipro Limited
Wipro is a multinational IT services provider based in Bengaluru, India. The company pivoted into the IT space in the 1980s and grew into one of the largest Indian IT consulting companies during the dot-com boom. Nowadays, Wipro leverages its offshore outsourcing model to derive a significant portion of its revenue from North America and Europe.
About GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).